Infectious Disease Clinical Trial Development Award

This funding call will support the formation of transdisciplinary teams led from Africa, South Asia or South-East Asia to develop an innovative idea for a future proposal for a clinical trial that optimises licensed infectious disease interventions to drive impact in low- and middle-income countries.

Funding Organization: Wellcome Trust in partnership with the Foreign, Commonwealth and Development Office (FCDO)

Scope: The pharmaceutical intervention (vaccine or therapeutic) must focus on one of the following disease areas:

• mycobacterial infections (tuberculosis, leprosy or infections with non-tuberculous mycobacteria)

• bacterial infections (sexually transmitted infections, lower respiratory tract infections or bloodstream infections)

• invasive fungal infections

• dengue, leishmaniasis or schistosomiasis  

Eligibility: The lead applicant and at least one coapplicant must be based in Africa, South Asia, or South-East Asia, and remain resident in that country for the duration of the award, at least 50 percent of applicants. Teams may include coapplicants based at eligible organizations in other parts of the world, apart from mainland China.

Maximum Award: The award provides up to 200,000 GBP for up to 24 months (possibly including indirect costs). Up to 20 awards will be provided.

Application Process: Applications must be submitted to the Wellcome Funding platform (https://funding.wellcome.org ). The funding webinar will be held on 23 March 2026 at 10am GMT (5PM in Bangkok). Register for the webinar at: https://wellcome-org.zoom.us/webinar/register/WN_28MyEY2VSiOlEQ4qrgVbLg#/registration

Application Deadline: 19 May 2026

Further information: https://wellcome.org/research-funding/schemes/infectious-disease-clinical-trial-development-award

—————————————————————————-

For more information, please contact

Ms. Panida Suwannatheerak and Ms. Mananchaya Pissaparn

Tel. 02 470 9654

Email: researchfollowup@kmutt.ac.th